Teriflunomide in relapsing multiple sclerosis: therapeutic utility

od Freedman, Mark S.
Wydane 2013

Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis

od Freedman, Mark S
Wydane 2014

Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome

od Freedman, Mark S.
Wydane w Ther Adv Neurol Disord (2014)

Multiple sclerosis therapeutic strategies: Use second-line agents as first-line agents when time is of the essence

od Freedman, Mark S.
Wydane w Neurol Clin Pract (2011)

Letter to the Editor: Consensus Statement on Neurofilament Proteins in Multiple Sclerosis Under Development by Consortium of Multiple Sclerosis Centers (CMSC) Expert Panel

od Freedman, Mark, Gnanapavan, Sharmilee
Wydane w Int J MS Care (2020)

Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned

od Atkins, Harold L., Freedman, Mark S.
Wydane 2012

Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis

od Atkins, Harold L., Freedman, Mark S.
Wydane w Neurotherapeutics (2017)

Clinical efficacy of teriflunomide over a fixed 2-year duration in the TOWER study

od Freedman, Mark S, Morawski, Julia, Thangavelu, Karthinathan
Wydane w Mult Scler J Exp Transl Clin (2018)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021

od Freedman, Mark S., Ault, Kevin, Bernstein, Henry
Wydane w MMWR Morb Mortal Wkly Rep (2021)

Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases

od D’Ambrosio, Daniele, Freedman, Mark S., Prinz, Joerg
Wydane w Ther Adv Chronic Dis (2016)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?

od Thebault, Simon, Booth, Ronald A., Freedman, Mark S.
Wydane w Biomedicines (2020)

HIV risks and testing behavior among Asians and Pacific Islanders: results of the HIV Testing Survey, 2002-2003.

od Kahle, Erin M., Freedman, Mark S., Buskin, Susan E.
Wydane 2005

Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis

od Freedman, Mark S, Kaplan, Johanne M, Markovic-Plese, Silva
Wydane 2013

Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis

od Rush, Carolina A., Atkins, Harold L., Freedman, Mark S.
Wydane w Cold Spring Harb Perspect Med (2019)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020

od Freedman, Mark S., Hunter, Paul, Ault, Kevin, Kroger, Andrew
Wydane w MMWR Morb Mortal Wkly Rep (2020)

Tolerability and discontinuation rates in teriflunomide-treated patients: A real-world clinical experience

od Alnajashi, Hind A., Alshamrani, Foziah J., Freedman, Mark S.
Wydane w Neurosciences (Riyadh) (2018)

Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-infected Men Who have Sex with Men in the United States

od Lin, Xia, Mattson, Christine L., Freedman, Mark, Skarbinski, Jacek
Wydane w AIDS Behav (2017)

A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo

od Vermersch, Patrick, Radue, Ernst-Wilhelm, Putzki, Norman, Ritter, Shannon, Merschhemke, Martin, Freedman, Mark S
Wydane w Mult Scler J Exp Transl Clin (2017)

Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation

od Thebault, Simon, Booth, Ronald A., Rush, Carolina A., MacLean, Heather, Freedman, Mark S.
Wydane w Front Neurosci (2021)

Research-to-Practice Gaps in Multiple Sclerosis Care for Patients with Subjective Cognitive, Mental Health, and Psychosocial Concerns in a Canadian Center

od Walker, Lisa A.S., Gardner, Courtney, Freedman, Mark S., MacLean, Heather, Rush, Carolina, Bowman, Marjorie
Wydane w Int J MS Care (2019)